Covid vaccines cut risk of virus-related heart failure and blood clots, study finds

Covid vaccines cut risk of virus-related heart failure and blood clots, study finds

This article is more than 2 years old

Researchers say jabs substantially reduce for up to a year the chances of serious cardiovascular complications

Covid vaccinations substantially reduce the risk of heart failure and potentially dangerous blood clots linked to the infection for up to a year, according to a large study.

Researchers analysed health records from more than 20 million people across the UK, Spain and Estonia and found consistent evidence that the jabs protected against serious cardiovascular complications of the disease.

Covid vaccines, including those from Oxford-AstraZeneca, Pfizer and Moderna, proved highly effective at preventing severe disease in the pandemic, but medicines regulators also recorded increases in some rare heart and clotting conditions, similar to those found with other vaccines such as flu shots.

The latest study sought to investigate the overall impact of a Covid vaccination, given that infection with the virus itself is known to significantly raise the risk of heart failure and various other serious cardiovascular problems.

“What we show in this very large study is that people who are vaccinated are at a very much reduced risk of these complications post-Covid,” said Daniel Prieto-Alhambra, a professor of pharmaco- and device epidemiology at the University of Oxford and a senior author on the study.

Writing in the journal Heart, the researchers describe how the adenovirus-based Covid vaccines produced by Oxford-AstraZeneca and Janssen, and the mRNA-based vaccines from Pfizer and Moderna, were most protective against Covid-related heart failure and blood clots in the first month after contracting the virus.

In that period, the risk of heart failure was 55% lower, and the risks of blood clots in the veins and arteries were down 78% and 47% respectively, compared with rates in unvaccinated people.

While the protective effects of the vaccines waned over the longer term, those who received Covid shots remained at lower risk of Covid-related heart failure and blood clots than unvaccinated individuals for up to a year, the researchers found.

Three to six months after infection, the risk of heart failure in vaccinated people was 39% lower than in unvaccinated people, with the risk of blood clots in the veins and arteries down 47% and 28% respectively. From six to 12 months post-infection, the risks of the same complications were 48%, 50% and 38% lower, respectively, for vaccinated people.

The protective effect arises from the vaccines reducing the severity of the disease when people experience breakthrough infections, when the virus takes hold despite a person being vaccinated.

“The message overall is that if you are vaccinated, your risk of having post-Covid cardiovascular and thromboembolic complications is reduced quite dramatically,” Prieto-Alhambra said. “Particularly for people who are at high risk, or are scared of having cardiovascular complications or blood clots, this is very reassuring.”

We know this is annoying … but this is your last chance to claim 50% off

Seeing these messages can be repetitive. We know that. (Imagine what it’s like writing them … )

But it’s also extremely important. One of the Guardian’s most valuable assets is its reader funding.

1. Reader funding means we can cover what we like. We’re not beholden to the political whims of a billionaire owner. No one can tell us what not to say or what not to report.

2. Reader funding means we don’t have to chase clicks and traffic. We’re not desperately seeking your attention for the sake of it: we pursue the stories that our editorial team deems important, and believe are worthy of your time.

3. Reader funding means we can keep our website open, allowing as many people as possible to read quality journalism from around the world – especially those who live in places where the free press is in peril.

Right now, the Guardian’s work is funded by just 2.4% of our regular readers. We know that not everyone can afford to pay for news, but if it would help to convince people like you from Morocco to support us, for a limited time, we’re offering 50% off for six months or 50% off an annual subscription to All-access digital and Digital plus. All-access digital gives you an enhanced, ad-free Guardian experience, while Digital Plus includes all the benefits of All-access digital, along with our 200-year archive, and digital versions of our daily newspaper and the Guardian Weekly. We value every contribution, but whether you choose All-access digital or Digital plus, you’ll be helping fund our most crucial, fearless journalism. As our thanks, we can offer you some great benefits (including making these messages go away). We’ve mad